FDA.reportPublic FDA data

RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream
Generic name
SALICYLIC ACID 3%
Manufacturer
RoyceDerm LLC
Product type
HUMAN OTC DRUG
SPL set ID
496e178b-e29b-071e-e063-6394a90aa018
SPL ID
496e178b-e29c-071e-e063-6394a90aa018
Version
1
Effective date
2026-01-28
Source export date
2026-08-01
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-08-01/4d7120b2932458966cd5c2f0e3ab49319f616f09498d059c9ff283a8dac64565/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
Import run
20260801T225920Z
Imported at
2026-08-01 23:10:48
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Ask a doctor before use you havea condition that covers a large area of the body. When usingthis product avoid contact with eyes. If contact occurs, rinse theeyes thoroughly with water. Stop and ask a doctor if conditionworsens or does not improve after regular use of this productas directed. If swallowed, getmedical help or contact a Poison Control Center right away.